No Data
No Data
Express News | MaxCyte, Inc. MaxCyte, Inc. - Mxcr - Strategic Platform License With TG Therapeutics
MaxCyte Signs Strategic Platform License With TG Therapeutics to Advance Its Autoimmune Cell Therapeutics Programs
Bank of America Securities Sticks to Its Sell Rating for TG Therapeutics (TGTX)
TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $50
All You Need to Know About TG Therapeutics (TGTX) Rating Upgrade to Buy
Institutional Investors Have a Lot Riding on TG Therapeutics, Inc. (NASDAQ:TGTX) With 75% Ownership
InvexGraphAi OP : $Staar Surgical (STAA.US)$ $Planet Labs PBC (PL.US)$$Alcoa (AA.US)$